Zynerba CEO talks through clinical updates for its lead indications and plans for 2022 January 17, 2022 admin CBD 0 Zynerba Pharmaceuticals Inc CEO Armando Anido talks to Proactive about program updates for Fragile X syndrome, autism …
Be the first to comment